Specialty pharmacies are an important resource for patients in need of access to specialty medications for complex conditions, such as cancer and multiple sclerosis.
Medication adherence, or the extent to which patients take medication as prescribed by their doctors, is a significant area of concern for both pharmacists and providers— especially when it comes to treating complex conditions like cancer and ...
Approximately 1 in 5 people with cancer in the U.S. are diagnosed with rare cancer. Although there is no universal definition, the National Cancer Institute defines rare cancers as fewer than 15 cases per 100,000 people per year. Other experts feel ...
Did you know that many HIV patients refuse to go to the hospital or receive medical treatment over fear of stigmatization and discrimination? Most people know that the virus is spread through sexual transmission, but falsely believe that you can ...
If you or a loved one has been diagnosed with EGFR positive, metastatic non-small cell lung cancer (NSCLC), you’re already facing a lot of decisions. These may include what type of treatment will work best for you. You and your doctor can work ...
Avella has always been dedicated to connecting its customers with the resources needed to make sound business and clinical decisions. Now we’ve introduced yet another way to do just that, with the release of our 2018 Specialty Medication Pipeline ...
Every day 115 Americans die because of an opioid overdose. That’s one person every 12.5 minutes. But what exactly is an opioid overdose? When taken in excess, opioids can slow down a person’s breathing and eventually cause the lungs and heart to ...
The specialty pharmacy industry is relatively young compared to other healthcare sectors, with its origins tracing back to the early 1970s. However, this industry’s explosive growth has certainly made up for its late start. Specialty drug spending ...
In the time since IMBRUVICA® (ibrutinib) was first approved by the FDA in 2013 it has undergone many changes. This includes multiple indication expansions to various types of leukemia and lymphoma, approval as a first-line therapy, and even ...
In today’s oncology landscape, new oral chemotherapy medications or updated indications are being released at an increasing rate. With each approval comes new hope for individuals and their families for a road to remission, and also a ...
